bioAffinity Technologies, Inc.
BIAF
$0.83
-$0.01-1.23%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.88M | -14.91M | -14.74M | -11.69M | -9.74M |
| Total Depreciation and Amortization | 464.80K | 504.90K | 534.80K | 572.70K | 610.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.17M | 4.48M | 4.65M | 2.02M | 1.03M |
| Change in Net Operating Assets | 331.30K | 594.20K | 1.11M | 1.42M | 1.53M |
| Cash from Operations | -10.91M | -9.33M | -8.45M | -7.68M | -6.56M |
| Capital Expenditure | -15.50K | -60.60K | -60.60K | -73.60K | -88.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.50K | -60.60K | -60.60K | -73.60K | -88.50K |
| Total Debt Issued | -- | -- | -96.90K | 165.00K | 164.10K |
| Total Debt Repaid | -349.10K | -369.80K | -354.10K | -488.20K | -411.60K |
| Issuance of Common Stock | 14.71M | 15.89M | 16.78M | 9.34M | 6.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -494.90K |
| Issuance of Preferred Stock | 990.00K | 990.00K | 990.00K | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.77M | -1.77M | -1.90M | -1.26M | -766.90K |
| Cash from Financing | 13.58M | 14.73M | 15.42M | 7.75M | 4.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.65M | 5.34M | 6.91M | 1.50K | -2.01M |